On Sept. 21, 2022, during United Nations General Assembly week, the Bill & Melinda Gates Foundation—alongside governments, philanthropies,…
On Sept. 20, 2022, health authorities in Uganda declared an outbreak of Ebola after a case of the…
On Sept. 20, 2022, the University of California, Davis announced that the amphibian decline in Latin America in…
On Sept. 17, 2022, the Democratic Republic of the Congo declared the end of an Ebola outbreak that…
On Sept. 16, 2022, Novavax announced that the Israel Ministry of Health has granted an import and use…
On Sept. 16, 2022, Novavax announced that the Taiwan Food and Drug Administration had granted expanded emergency use…
On Sept. 15, 2022, the National Institutes of Health (NIH) announced that a research team funded by the…
On Sept. 15, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Sept. 15, 2022, Gilead Sciences announced updates to the World Health Organization’s (WHO) Therapeutics and COVID-19: living…
On Sept. 13, 2022, Novavax and Serum Institute of India, the world’s largest vaccine manufacturer by volume, announced…
On Sept. 8, 2022, a clinical trial evaluating alternative strategies for administering the JYNNEOS mpox vaccine to increase…
On Sept. 7, 2022, Quest Diagnostics announced that it had received emergency use authorization (EUA) from the U.S….
On Sept. 2, 2022, Novavax announced that Swissmedic, the Swiss Agency for Therapeutic Products, had expanded its temporary…
On Sept. 2, 2022, Novavax announced that Swissmedic, the Swiss Agency for Therapeutic Products, had expanded its temporary…
On Sept. 1, 2022, Novavax announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine had been recommended for expanded conditional marketing…
On Aug. 29, 2022, the U.S. Department of Health and Human Services (HHS) announced it had provided approximately…
On Aug. 26, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
On Aug. 23, 2022, Pfizer and BioNTech announced updated efficacy results from a Phase 2/3 trial evaluating a…
On Aug. 23, 2022, Health authorities in the Democratic Republic of the Congo declared a resurgence of Ebola…
On Aug. 22, 2022, Pfizer and BioNTech announced they had completed a submission to the U.S. Food and…
On Aug. 22, 2022, Moderna announced it has applied for an U.S. Food and Drug Administration (FDA) emergency…
On Aug. 23, 2022, Moderna announced they will supply 12 million doses of its COVID-19 shot adapted to…
On Aug. 19, 2022, Novavax announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) had received expanded emergency use…
On Aug. 18, 2022, Novavax announced that New Zealand’s Medsafe had granted expanded provisional approval for Nuvaxovid (NVX-CoV2373)…
On Aug. 18, 2022, the White House announced that the U.S. Department of Health and Human Services (HHS)…
On Aug. 15, 2022, Moderna announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK…
On Aug. 15, 2022, the U.S. Department of Health and Human Services announced that was making up to…
On Aug. 15, 2022, Roche announced the launch of the Elecsys IGRA SARS-CoV-2 test in countries that accept…
On Aug. 12, 2022, a group of global experts convened by WHO agreed on new names for monkeypox…
On Aug. 12, 2022, Novavax announced that partner, SK bioscience, had received a Post Approval Change Application approval…